91 related articles for article (PubMed ID: 10660738)
1. [Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
Basaki Y; Yonekura K; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Aoyagi K; Yamada Y
Gan To Kagaku Ryoho; 2000 Jan; 27(1):93-8. PubMed ID: 10660738
[TBL] [Abstract][Full Text] [Related]
2. [Anti-metastatic and anti-angiogenic activity of UFT in a lung spontaneous metastasis model in mice].
Basaki Y; Shibata J; Murakami K; Hashimoto A; Yonekura K; Fukushima M; Yamada Y
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1607-12. PubMed ID: 10553418
[TBL] [Abstract][Full Text] [Related]
3. [Gamma-hydroxybutyric acid, a metabolite of UFT, shows anti-angiogenic activities and antitumor effect].
Basaki Y; Miyadera K; Yonekura K; Aoyagi K; Chikahisa L; Okabe S; Hashimoto A; Kitazato K
Gan To Kagaku Ryoho; 2002 Jan; 29(1):89-94. PubMed ID: 11816484
[TBL] [Abstract][Full Text] [Related]
4. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
[TBL] [Abstract][Full Text] [Related]
5. UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.
Basaki Y; Aoyagi K; Chikahisa L; Miyadera K; Hashimoto A; Yonekura K; Okabe S; Shibata J; Wierzba K; Yamada Y
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):68-71. PubMed ID: 11098498
[TBL] [Abstract][Full Text] [Related]
6. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
Yonekura K; Basaki Y; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Wierzba K; Yamada Y
Clin Cancer Res; 1999 Aug; 5(8):2185-91. PubMed ID: 10473104
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of gamma-hydroxybutylic acid (GHB) and gamma-butyrolactone (GBL), the anti-angiogenic metabolites of oral fluoropyrimidine UFT, in patients with gastric cancer.
Emi Y; Sumiyoshi Y; Oki E; Kakeji Y; Fukui Y; Maehara Y
Fukuoka Igaku Zasshi; 2007 Dec; 98(12):418-24. PubMed ID: 18260367
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].
Fujioka T; Hasegawa M; Ishikura K; Nomura K; Okamoto T; Tanji S; Koike H; Kubo T
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2031-6. PubMed ID: 2221926
[TBL] [Abstract][Full Text] [Related]
9. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
[TBL] [Abstract][Full Text] [Related]
10. [In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice].
Niimi K; Nishiyama M; Hirabayashi N; Yamaguchi M; Nosoh Y; Wang DC; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1281-5. PubMed ID: 3107479
[TBL] [Abstract][Full Text] [Related]
11. [In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay].
Nishiyama M; Niimi K; Yamaguchi M; Hirabayashi N; Nosoh Y; Tohge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):109-13. PubMed ID: 3099648
[TBL] [Abstract][Full Text] [Related]
12. Formation pathways of gamma-butyrolactone from the furan ring of tegafur during its conversion to 5-fluorouracil.
Yamamiya I; Yoshisue K; Matsushima E; Nagayama S
Drug Metab Dispos; 2010 Aug; 38(8):1267-76. PubMed ID: 20463005
[TBL] [Abstract][Full Text] [Related]
13. UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.
Nagai N; Mukai K; Hirata E; Jin HH; Komatsu M; Yunokawa M
Med Oncol; 2008; 25(2):214-21. PubMed ID: 17968681
[TBL] [Abstract][Full Text] [Related]
14. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
[TBL] [Abstract][Full Text] [Related]
15. Life prolonging effect of antitumor agents on postoperative adjuvant therapy in the lung spontaneous metastasis model in mice.
Shibata J; Murakami K; Abe M; Hashimoto A; Utsugi T; Fukushima M; Yamada Y
Anticancer Res; 1998; 18(2A):1203-9. PubMed ID: 9615789
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of UFT in prostatic carcinoma (DU-145) in nude mice].
Kagawa S; Takigawa H; Aga Y; Kurokawa K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3408-12. PubMed ID: 3098182
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of prostatic carcinoma with UFT and leucovorin--basic study using SRCA].
Uchida K; Hayashi T; Shiga T; Hattori K; Nishijima Y; Kasaya S; Shimazui T; Akaza H; Koiso K; Nemoto R
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2633-7. PubMed ID: 7979424
[TBL] [Abstract][Full Text] [Related]
18. [A sensitivity test of UFT and FT-207 against human pulmonary cancer using nude mice].
Urabe N; Momiki S; Shiba M; Yamaguchi Y
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2224-8. PubMed ID: 3136694
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor.
Funahashi Y; Wakabayashi T; Semba T; Sonoda J; Kitoh K; Yoshimatsu K
Oncol Res; 1999; 11(7):319-29. PubMed ID: 10757446
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole augments the antitumor effects of fluorinated pyrimidines.
Sakaguchi Y; Kusumoto T; Kusumoto H; Maehara Y; Furusawa M; Sugimachi K
Anticancer Res; 1992; 12(1):119-21. PubMed ID: 1567156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]